Quadriceps Muscle Quality and Clinical Outcomes in Knee Osteoarthritis
Key facts
- Who runs it
- Izmir City Hospital
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 60 people enrolled
- Started
- 14 Apr 2026
- Ended
- 28 Sept 2026
- Type of study
- Observational, 2 groups
- Record updated
- 1 October 2026
Who can take part
- Age
- 40 years to 70 years
- Sex
- Women only
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Female sex
- Aged between 40 and 70 years
- Diagnosed with clinical and radiographic primary knee osteoarthritis (Kellgren-Lawrence Grade 2 or 3)
- Ability to perform isometric contraction at 90° of knee flexion
- Voluntary participation and provision of written informed consent
Who cannot take part
- Intra-articular injection (e.g., corticosteroids, hyaluronic acid) within the last 3 months
- History of knee surgery within the last 6 months
- Presence of inflammatory rheumatic diseases (e.g., Rheumatoid Arthritis, Spondyloarthropathy)
- Known neuromuscular disorders affecting the lower extremities
- Severe cardiopulmonary comorbidities that prevent participation in clinical assessments
- Severe patellofemoral instability
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The purpose of this cross-sectional, observational study is to evaluate the relationship between quadriceps muscle quality-specifically muscle echogenicity and thickness change during isometric contraction-and clinical outcomes such as pain, physical function, quality of life, and Patient Global Assessment (PtGA) in female patients with knee osteoarthritis. Participants will undergo a non-invasive ultrasound evaluation of their thigh muscles and complete standard clinical questionnaires to help determine how muscle structural and functional properties impact the daily lives of patients with knee osteoarthritis.
The 2 groups in the trial
- Female Patients with Knee Osteoarthritis
This group consists of female patients aged 40-70 years diagnosed with primary knee osteoarthritis (Kellgren-Lawrence Grade 2 and 3) according to the American College of Rheumatology (ACR) criteria. All participants in this cohort will undergo: 1. Ultrasonographic Assessment: Measurement of Rectus Femoris and Vastus Intermedius muscle thickness at rest and during maximum voluntary isometric contraction, along with muscle echogenicity analysis. 2. Clinical Evaluation: Assessment of pain intensity via Visual Analog Scale (VAS), and evaluation of functional status and quality of life using the Knee Injury and Osteoarthritis Outcome Score (KOOS) and Patient Global Assessment (PtGA).
- Healthy Control Group
This group consists of healthy female volunteers aged 40-70 years with no clinical or radiographic evidence of knee osteoarthritis and no history of chronic knee pain. Participants in this control group will undergo the same standardized evaluation protocol as the patient group to provide baseline values for: 1. Ultrasonographic Assessment: Measurement of Rectus Femoris and Vastus Intermedius muscle thickness at rest and during maximum voluntary isometric contraction, along with muscle echogenicity analysis. 2. Clinical Evaluation: Assessment of pain intensity via Visual Analog Scale (VAS), and evaluation of functional status and quality of life using the Knee Injury and Osteoarthritis Outcome Score (KOOS) and Patient Global Assessment (PtGA).
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Relationship of Quadriceps Muscle Echogenicity and Thickness Change During Isometric Contraction With Pain, Function, Quality of Life, and Patient Global Assessment in Knee Osteoarthritis
- Record updated
- 1 October 2026